China Battles Whooping Cough Surge with Vaccination Push

China is currently experiencing a significant increase in whooping cough cases, with reported figures reaching a level not seen in four decades. The number of cases in 2024 has surged to nearly half a million, representing a substantial increase compared to the previous year. Infants, especially those under one year old, are the most susceptible to the illness.

In response to the rise in cases, a national campaign has been initiated to educate families about the risks associated with whooping cough and the importance of timely vaccination. The campaign emphasizes the role of vaccines as the primary defense against infectious diseases.

A key development in the fight against pertussis is the upcoming change to China's immunization program. Starting in January 2025, the first dose of the DTaP vaccine will be administered at two months of age. This earlier vaccination schedule is designed to provide infants with earlier protection.

Research indicates that an accelerated vaccination schedule can significantly reduce the incidence of whooping cough in infants. Experts are encouraging parents to ensure their children complete the recommended vaccination schedule.

Beyond the initial doses, children require booster shots to maintain long-term protection. These boosters are typically administered at 18 months and 6 years of age.

Experts are also highlighting the advantages of combination vaccines. These vaccines offer broader protection while reducing the number of injections required, potentially minimizing adverse reactions.